A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|6|338-349

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.6, 2015-06, pp. : 338-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

By Johnson Trevor N.   Boussery Koen   Rowland-Yeo Karen   Tucker Geoffrey T.   Rostami-Hodjegan Amin  

Clinical Pharmacokinetics, Vol. 49, Iss. 3, 2010-03 ,pp. : 189-206

Adis International

Access to resources Recommend Favorite

Screening for liver cancer worth it in cirrhosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Screening for liver cancer worth it in cirrhosis

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Considerations in Development of a Bioartificial Liver

By Iwata H.   Ueda Y.  

Clinical Pharmacokinetics, Vol. 43, Iss. 4, 2004-01 ,pp. : 211-225

Adis International

Access to resources Recommend Favorite

Level of nitrated proteins in the plasma, platelets and liver of patients with liver cirrhosis

By Annie-Jeyachristy Sam   Geetha Arumugam   Surendran Rajagopal   Sundaram Arunachalam   Lavanya Krishnagopal   Kumar Subburayan Jeevan   Prakash Sarangapani Arul  

Redox Report, Vol. 14, Iss. 6, 2009-12 ,pp. : 259-266

Maney Publishing

Access to resources Recommend Favorite